NIH – Exploratory Alzheimer’s Disease Research Centers (P20 Clinical Trial Not Allowed)

June 7, 2019 by


This Funding Opportunity Announcement (FOA) invites applications to establish NIA Exploratory Alzheimer’s Disease Centers. NIA’s primary goal in offering this P20 funding opportunity is to incentivize innovative ideas and opportunities in Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) research. As part of a network, Centers are expected to participate in collaborative efforts on a national scale. Applicants must agree to collect a standard clinical data set (the Uniform Data Set, or UDS) that is common to all Centers and to transmit that data to the National Alzheimer’s Coordinating Center (NACC). Applicants should contact NACC to learn more about NACC procedures, the structure of the UDS, and the regular updates to the datasets required from all Centers at

Funds Available:

NIH intends to fund up to two (2) awards, corresponding to a total of $1.5 million in direct costs, for Fiscal Year 2020. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Key Dates:

Open Date (Earliest Submission Date): September 9, 2019
Letter of Intent Due Date(s): September 9, 2019
Application Due Date(s): October 9, 2019, by 5:00 PM local time of applicant organization.
Hyperlink for more information:

Filed Under: Featured, Funding Opportunities